Master the upcoming ICD-10 code and IPPS changes! Prepare your team for the upcoming changes taking effect on October 1. Discover the benefits of IPPSPalooza and how it can drive your success. Click here >

Buprenorphine Prescribing to Increase with HHS Removal of X-Waiver

In a stunning move, the U.S. Department of Health and Human Services (HHS) just announced that it is eliminating the need for providers to have a special waiver from the Drug Enforcement Administration (DEA) to prescribe medication-assisted treatment (MAT) for opioid use disorder.

Approved by the Food and Drug Administration (FDA) in 2002, buprenorphine, either with or without naloxone (and marketed as Subuxone and Subutex), is an effective treatment for opioid use disorder when combined with counseling. Prior to this notice, if a provider wanted to prescribe buprenorphine, they had to complete an eight-hour training program and then apply to the DEA for a special addition to their controlled substance prescribing license. Providers were initially limited to 30 patients. These requirements and restrictions for a very effective medication limited its use in primary care, and resulted in a demand that far exceeded the supply.

Buprenorphine is highly effective in treatment, with the medication occupying the Mu-opioid receptors that create the craving for opioids, but without producing the euphoria of opioids. If a patient taking buprenorphine does take an opioid by any mode, they do not get the usual effect, again leading to a reduction in desire. In one controlled trial over one year, buprenorphine was 75 percent effective in preventing relapse, while placebo was 0 percent effective, with 20 percent of the placebo group dying in that year.

The use of medication-assisted treatment is occasionally viewed as “substituting one opioid for another,” and use of MAT often carries a stigma, with some suggesting that patients simply need to stop using opioids completely. While this is technically correct, it is no different than saying that a type I diabetic should not be given insulin, since it is simply replacing their body’s insulin, and they just need to work harder at making their own instead of relying on an exogenous source. MAT should be combined with counseling and support services, just as diabetics should also receive education about diet and exercise, and be monitored closely.

This change will be especially welcome by emergency medicine physicians, who often treat patients with opioid overdose or withdrawal, but were previously limited to prescribing only 72 hours’ worth of medication that had to be administered in the emergency department (and then often had difficulty finding providers in the community that had the X-waiver and could continue to provide prescriptions to the patient). These ED physicians can now start buprenorphine treatment, provide a prescription for the medication, and refer the patient to an outpatient provider to continue treatment. This will take close coordination between hospital- and community-based providers – a team effort with involvement of the ED physician, the social worker, the pharmacist, and all the community-based providers – but the efforts should result in a reduction in the morbidity and mortality associated with opioid use disorder.

The HHS notice can be read here: https://www.hhs.gov/about/news/2021/01/14/hhs-expands-access-to-treatment-for-opioid-use-disorder.html

The American College of Emergency Physicians page on buprenorphine in the ED can be found here: https://www.acep.org/patient-care/bupe/

Programming Note: Listen to Dr. Ronald Hirsch every Monday on Monitor Mondays, 10 a.m. Eastern, sponsored by R1-RCM.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn
Email
Print

Ronald Hirsch, MD, FACP, CHCQM, CHRI

Ronald Hirsch, MD, is vice president of the Regulations and Education Group at R1 Physician Advisory Services. Dr. Hirsch’s career in medicine includes many clinical leadership roles at healthcare organizations ranging from acute-care hospitals and home health agencies to long-term care facilities and group medical practices. In addition to serving as a medical director of case management and medical necessity reviewer throughout his career, Dr. Hirsch has delivered numerous peer lectures on case management best practices and is a published author on the topic. He is a member of the Advisory Board of the American College of Physician Advisors, a member of the American Case Management Association, and a Fellow of the American College of Physicians. Dr. Hirsch is a member of the RACmonitor editorial board and is regular panelist on Monitor Mondays. The opinions expressed are those of the author and do not necessarily reflect the views, policies, or opinions of R1 RCM, Inc. or R1 Physician Advisory Services (R1 PAS).

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering the Two-Midnight Rule: Keys to Navigating Short-Stay Admissions with Confidence

Mastering the Two-Midnight Rule: Keys to Navigating Short-Stay Admissions with Confidence

The CMS Two-Midnight Rule and short-stay audits are here to stay, impacting inpatient and outpatient admissions, ASC procedures, and Medicare Parts C & D. New for 2024, the Two-Midnight Rule applies to Medicare Advantage patients, requiring differentiation between Medicare plans affecting Case Managers, Utilization Review, and operational processes and knowledge of a vital distinction between these patients that influences post-discharge medical reviews and compliance risk. Join Michael G. Calahan for a comprehensive webcast covering federal laws for all admission processes. Gain the knowledge needed to navigate audits effectively and optimize patient access points, personnel, and compliance strategies. Learn Two-Midnight Rule essentials, Medicare Advantage implications, and compliance best practices. Discover operational insights for short-stay admissions, outpatient observation, and the ever-changing Inpatient-Only Listing.

Print Friendly, PDF & Email
September 19, 2023
Secondary Diagnosis Coding: A Deep Dive into Guidelines and Best Practices

Secondary Diagnosis Coding: A Deep Dive into Guidelines and Best Practices

Explore comprehensive guidelines and best practices for secondary diagnosis coding in our illuminating webcast. Delve into the intricacies of accurately assigning secondary diagnosis codes to ensure precise medical documentation. Learn how to navigate complex scenarios and adhere to coding regulations while enhancing coding proficiency. Our expert-led webcast covers essential insights, including documentation requirements, sequencing strategies, and industry updates. Elevate your coding skills and stay current with the latest coding advancements so you can determine the correct DRG assignment to optimize reimbursement, support medical decision-making, and maintain compliance.

Print Friendly, PDF & Email
September 20, 2023
Principal Diagnosis Coding: Mastering Selection and Sequencing

Principal Diagnosis Coding: Mastering Selection and Sequencing

Enhance your inpatient coding precision and revenue with Principal Diagnosis Coding: Mastering Selection and Sequencing. Join our expert-led webcast to conquer the challenges of principal diagnosis selection and sequencing. We’ll decode the intricacies of ICD-10-CM guidelines, equipping you with a clear grasp of the rules and the official UHDDS principal diagnosis definition. Uncover the crucial role of coding conventions, master the sequencing of related conditions, and confidently tackle cases with equally valid principal diagnoses.

Print Friendly, PDF & Email
September 14, 2023
2024 IPPS Summit: Final Rule Update with Expert Insights and Analysis

2024 IPPS Summit: Final Rule Update with Expert Insights and Analysis

Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY24 Inpatient Prospective Payment System (IPPS) Final Rule, including new ICD-10-CM/PCS codes, plus insights, analysis and answers to questions from the country’s most respected subject matter experts.

Print Friendly, PDF & Email
2024 IPPS Summit Day 3: MS-DRG Shifts and NTAPs

2024 IPPS Summit Day 3: MS-DRG Shifts and NTAPs

This third session in our 2024 IPPS Summit will feature a review of FY24 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by senior healthcare consultant Laurie Johnson, with bonus insights and analysis from two acclaimed subject matter experts

Print Friendly, PDF & Email
August 17, 2023

Trending News